Furthermore, consistent with existing literature, our WB analysis confirmed that SRPK1 exerted oncogenic effects via activating the PI3K/AKT/GSK3β signaling pathway in HCC cells. This evidence concerns the gene GSK3B and hepatocellular carcinoma.